Research Article
Effects of a Flexibility and Relaxation Programme, Walking, and Nordic Walking on Parkinson's Disease
Table 2
Medication used by the patient groups.
| Medication | Relaxation and flexibility group
| Walking group
| Nordic walking group
| | Total number | (%) | Total number | (%) | Total number | (%) |
| Levodopa | 20 | 66 | 22 | 73.3 | 20 | 66.7 | Dopamine agonists | 27 | 90 | 26 | 86.7 | 26 | 86.7 | Mao-Inhibitor | 12 | 40 | 13 | 43.3 | 12 | 40 | COMT-Inhibitor | 11 | 36.7 | 12 | 40 | 10 | 33 | Amantadine | 10 | 33 | 10 | 33 | 9 | 30 | -blockers | 4 | 13.3 | 3 | 10 | 3 | 10 | ACE-inhibitors | 3 | 10 | 3 | 10 | 3 | 10 | Antidepressants | 7 | 23.3 | 8 | 26.7 | 8 | 26.7 |
|
|
(%) = percentage.
|